Patents Assigned to Curatek Pharmaceuticals, Inc.
  • Patent number: 4837378
    Abstract: Topical aqueous single-phase compositions containing metronidazole are disclosed. The compositions have improved specific activity and are substantially non-comedogenic, non-irritating and non-skin-drying. These aqueous topical compositions are particularly useful for treating rosacea and other acneform dermatological conditions, and certain forms of dermatitis.
    Type: Grant
    Filed: January 15, 1988
    Date of Patent: June 6, 1989
    Assignee: Curatek Pharmaceuticals, Inc.
    Inventor: Robert J. Borgman